Gilead fills CMO spot with Genentech exec Parsey

Gilead hired Merdad Parsey as CMO, filling a position that has been vacant for over a year at a company that has seen several high level departures since Chairman and CEO Daniel O'Day took the helm this year.

Parsey will succeed Andrew Cheng, who stepped down as CMO in September 2018 to join NASH company Akero Therapeutics Inc. (Cambridge, Mass.) as president and CEO. ...